Monopar Therapeutics Stock News & Updates
[WKN: A40JML | Symbol: MNPR]
Monopar Therapeutics
Analysts' Top 5 Price Targets of July 7, 2025
Monopar Therapeutics: Progress in Radiopharmaceutical Research and Development of ALXN1840, Analyst Support, and Index Inclusion!
Monopar Therapeutics Inc. (MNPR) has made significant progress in the development of its radiopharmaceutical...
Monopar Therapeutics (MNPR): Piper Sandler sees potential for ALXN1840 in treating Wilson disease
Monopar Therapeutics Inc. (MNPR) is a biotechnology company focused on developing innovative treatments...
Analysts' Top 5 Price Targets of May 19, 2025
Befesa [LU1704650164]: Hauck Aufhäuser reaffirms Buy rating and raises price target from €35 to €42...
- ‹
- 1
- ›